These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10516525)

  • 1. Natural interferon therapy: optic nerve ischemic damage?
    Norcia F; Di Maria A; Prandini F; Redaelli C
    Ophthalmologica; 1999; 213(5):339-40. PubMed ID: 10516525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bilateral non-arteritic ischemic optic neuropathy during treatment of viral hepatitis C with pegylated interferon and Ribavirin].
    Iferkhass S; Elasri F; Chatioui S; Khoyaali A; Bargach T; Reda K; Oubaaz A
    J Fr Ophtalmol; 2015 Jan; 38(1):34-40. PubMed ID: 25533994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterior ischemic optic neuropathy complicating interferon alpha and ribavirin therapy in patients with chronic hepatitisC.
    Kabbaj N; Sentissi S; Mohammadi M; Benaïssa A; Amrani N
    Gastroenterol Clin Biol; 2009 Feb; 33(2):115-7. PubMed ID: 19201118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterior ischemic optic neuropathy associated with pegylated interferon therapy for chronic hepatitis C.
    Wei YH; Wang IH; Woung LC; Jou JR
    Ocul Immunol Inflamm; 2009; 17(3):191-4. PubMed ID: 19585362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peripheral polyneuropathy and bilateral optic neuropathy during treatment of chronic hepatitis C].
    Chrissafidou A; Musch E
    Dtsch Med Wochenschr; 2009 Apr; 134(18):927-30. PubMed ID: 19384811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal complications and plasma C5a levels during interferon alpha therapy for chronic hepatitis C.
    Sugano S; Suzuki T; Watanabe M; Ohe K; Ishii K; Okajima T
    Am J Gastroenterol; 1998 Dec; 93(12):2441-4. PubMed ID: 9860406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is screening for interferon retinopathy in hepatitis C justified?
    Cuthbertson FM; Davies M; McKibbin M
    Br J Ophthalmol; 2004 Dec; 88(12):1518-20. PubMed ID: 15548803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central vein occlusion in a patient using interferon and ribavirin: case report].
    Helal J; Zacharias LC; de Alencar LM
    Arq Bras Oftalmol; 2006; 69(4):601-4. PubMed ID: 17119740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinopathy in chronic hepatitis C patients during interferon treatment: a case report.
    Rossi C; Scotton PG; Farina F; Vaglia A
    Infez Med; 2010 Dec; 18(4):267-9. PubMed ID: 21196822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal toxicity during pegylated alpha-interferon therapy for chronic hepatitis C: a multifocal electroretinogram investigation.
    Chisholm JA; Williams G; Spence E; Parks S; Keating D; Gavin M; Mills PR
    Aliment Pharmacol Ther; 2005 Mar; 21(6):723-32. PubMed ID: 15771758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reversible Perimacular Retinopathy by Long-Time Interferon alpha Therapy].
    Sandner D; Pillunat LE
    Klin Monbl Augenheilkd; 2004 Jan; 221(1):63-6. PubMed ID: 14745683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C.
    Adams S; Ostermeier M
    Optometry; 2010 Nov; 81(11):580-6. PubMed ID: 20655283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C.
    Kasahara A; Hiraide A; Tomita N; Iwahashi H; Imagawa A; Ohguro N; Yamamoto S; Mita E; Hayashi N
    J Gastroenterol; 2004 Nov; 39(11):1106-9. PubMed ID: 15580406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
    Burgueño-Montañés C; Pérez-Álvarez R
    Arch Soc Esp Oftalmol; 2011 Jun; 86(6):193-5. PubMed ID: 21767697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b.
    Neglia V; Sookoian S; Herrera M; Abeldaño A; Kien MC; Chouela E; Frider B
    J Cutan Med Surg; 2001; 5(5):406-8. PubMed ID: 11915769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does ascorbic acid prevent retinopathy during interferon therapy in patients with chronic hepatitis C?
    Nishiguchi S; Shiomi S; Enomoto M; Lee C; Jomura H; Tamori A; Habu D; Takeda T; Yanagihara N; Shiraki K
    J Gastroenterol; 2001 Jul; 36(7):486-91. PubMed ID: 11480793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined central retinal vein and central retinal artery occlusions and neovascular glaucoma associated with interferon treatment.
    Rachitskaya AV; Lee RK; Dubovy SR; Schiff ER
    Eur J Ophthalmol; 2012; 22(2):284-7. PubMed ID: 21928253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.
    Schulman JA; Liang C; Kooragayala LM; King J
    Ophthalmology; 2003 Feb; 110(2):437-42. PubMed ID: 12578794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retinopathy during interferon treatment in combination with ribavirin for chronic hepatitis C].
    Nakamura T; Takahashi H; Koike N; Mitsutaka M; Soda M; Kimu M
    Nippon Ganka Gakkai Zasshi; 2005 Nov; 109(11):748-52. PubMed ID: 16363669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha-associated bilateral simultaneous ischemic optic neuropathy.
    Vardizer Y; Linhart Y; Loewenstein A; Garzozi H; Mazawi N; Kesler A
    J Neuroophthalmol; 2003 Dec; 23(4):256-9. PubMed ID: 14663304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.